Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings

Epilepsy Research

Volumn 70, Issue 2-3, 2006, Pages 190-199

  Clemens, Béla ^a   Ménes, Andrea ^a   Piros, Pálma ^a   Bessenyei, Mónika ^a   Altmann, Anna ^b   Jerney, Judit ^b   Kollár, Katalin ^c   Rosdy, Beáta ^c   Rózsavölgyi, Margit ^d   Steinecker, Katalin ^e   Hollódy, Katalin ^f  

^a Kenezy Korhaz Rendelointezet   (Hungary)

^b Buda Children's Hospital   (Hungary)

^c HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

^d Central Military Hospital Budapest   (Hungary)

^e Veszprem County Hospital   (Hungary)

^f UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Carbamazepine; Cognitive impairment; Lamotrigine; Neurotoxicity; Oxcarbazepine; Quantitative EEG; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; OXCARBAZEPINE; VALPROIC ACID;

ADOLESCENT; ADULT; ALPHA RHYTHM; ARTICLE; BETA RHYTHM; CALCULATION; CENTRAL NERVOUS SYSTEM; CHILD; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAMETER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ROLANDIC EPILEPSY; STATISTICAL SIGNIFICANCE; THETA RHYTHM; WAKEFULNESS;

EID: 33746930304     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2006.05.003     Document Type: Article

References (37)

1. Aldenkamp A.P. Effects of antiepileptic drugs on cognition. Epilepsia 42 Suppl. (2001) 46-49
2. Aldenkamp A.P., Arends J., Bootsma H.P.R., Diepman L., Hulsman J., Lambrechts D., Leenen L., Majoie M., Schellekens A., and de Vocht J. Randomized double-blind parallel-group study comparing cognitive effects of a low dose lamotrigine with valproate. Epilepsia 43 (2002) 19-26
3. Ambrosetto G., Rossi P.G., and Tassinari A. Predictive factors of seizure frequency and duration on antiepileptic treatment in rolandic epilepsy: a retrospective study. Brain Dev. 9 (1987) 300-304
4. Angelaikis E., Lubar J.F., Stathopoulou A., and Kuonios J. Peak alpha frequency: an electroencephalographic measure of cognitive preparedness. Clin. Neurophysiol. 115 (2004) 887-897
5. Basar E., and Schürmann M. Brain functioning: integrative models. In: Basar E. (Ed). Brain Function and Oscillations. Vol. II: Integrative Brain Function. Neurophysiology and Cognitive Processes (1999), Springer, Berlin 393-406
6. Besser R., Hornung K., Theisonh M., Rothacher G., and Krämer G. EEG changes in patients during the introduction of carbamazepine. Electroenceph. Clin. Neurophysiol. 83 (1992) 19-23
7. Clemens B., and Barta Z. Valproate treatment normalises EEG frequency profiles in idiopathic (primary) generalised epilepsy (In Hungarian English Abstract). Clin. Neurosci./Ideggy Szle 52 (1999) 307-317
8. Clemens B., and Bessenyei M. Occipital spectral EEG-parameters in newly diagnosed, untreated epilepsy patients (In Hungarian English Abstract). Clin. Neurosci./Ideggy Szle 56 (2003) 92-105
9. Clemens B., Ménes A., and Nagy Z. Objective assessment of neurotoxicity while shifting from carbamazepine to oxcarbazepine. Acta Neurol. Scand. 109 (2004) 324-329
10. Cornaggia C.M., and Goggi G. Learning disability in epilepsy: definitions and classification. Epilepsia 42 suppl. 1 (2001) 2-5
11. Frost J.D., Hrachovy R.A., Glaze D.G., and Rettig G.M. Alpha rhythm slowing during initiation of carbamazepine therapy: implications for future cognitive performance. J. Clin. Neurophysiol. 12 (1995) 57-63
12. Gasser T., Bacher P., and Steinberg H. Test-retest reliability of spectral parameters of the EEG. Electroenceph. Clin. Neurophysiol. 60 (1985) 312-319
13. ILAE. Commission on classification and terminology: proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 (1989) 389-399
14. John E.R., Prichep L., Ahn H., Easton P., Fridman J., and Kaye H. Neurometric evaluation of cognitive dysfunctions and neurological disorders in children. Progr. Neurobiol. 21 (1983) 290-329
15. Klimesch W. EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res. Rev. 29 (1999) 169-195
16. Konishi T., Naganuma Y., Honguo K., Murakami M., Yamatani M., and Okada T. Effects of antiepileptic drugs on EEG background activity in children with epilepsy. Clin. Electroenceph. 26 (1995) 113-119
17. Kwan P., and Brodie M.J. Effectiveness of first antiepileptic drug. Epilepsia 42 (2002) 1255-1260
18. Lammers M.W., Hekster Y.A., Keyser A., van Lier H., Minardi H., and Renier W.O. Neither dosage nor serum levels of the antiepileptic drugs are predictive for efficacy and adverse effects. Pharm. World Sci. 17 (1995) 201-206
19. In: Levy R.H., Mattson R.H., and Meldrum B.S. (Eds). Antiepileptic drugs. 4th ed. (1995), Lippincott-Raven Healthcare, New Jersey
20. Liu R.S., Lemieux L., Bell G.S., Hammers A., Sisodiya S.M., Bartlett P.A., Shorvon S.D., Sander J.W., and Duncan J.S. Progressive neocortical damage in epilepsy. Ann. Neurol. 53 (2003) 312-324
21. Mattson R.H., and Cramer J.A. Quantitative assessment of adverse drug effects. In: Meinardi H. (Ed). Quantitative Assessment in Epilepsy Care (1993), Plenum Press, New York 123-135
22. Meador K.J., Loring D.W., Abney O.L., Allen M.E., Moore E.E., Zamrini E.Y., and King D.W. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 34 (1993) 153-157
23. Novelly R.A., Schwartz M.M., Mattson R.H., and Cramer J.A. Behavioral toxicity associated with antiepileptic drug: concepts and methods of assessment. Epilepsia 27 (1986) 331-340
24. Nunez P.L., Wingeier B.M., and Silberstein R.B. Spatio-temporal structures of human alpha rhythms: theory, microcurrent sources, multiscale measurements, and global binding of local networks. Hum. Brain Mapping 13 (2001) 125-164
25. Nuwer M. Quantitative EEG. 1. Techniques and problems of frequency analysis and topographic mapping. J. Clin. Neurophysiol. 5 (1988) 1-43
26. Nuwer M. Quantitative EEG: 2. Frequency analysis and topographic mapping in clinical settings. J. Clin. Neurophysiol. 5 (1988) 45-85
27. Nuwer M., Lehmann D., Lopes da Silva F., Matsuoka S., Sutherling W., and Vibert J.F. IFCN guidelines for topographic and frequency analysis of EEGs and EPs. Report of an IFCN committee. Electroenceph. Clin. Neurophysiol. 91 (1994) 1-5
28. Pellock J.M. Carbamazepine side effects in children and adults. Epilepsia 28 Suppl. 3 (1987) S64-S70
29. Saletu B., Anderer P., Kinsperger K., and Grünberger J. Topographic brain mapping of EEG in neuropsychopharmacology. Part II. Clinical applications (Pharmaco EEG imaging). Meth. Find. Exp. Clin. Pharmacol. 9 (1987) 385-408
30. Saletu B., Anderer P., Saletu-Zyhlarz A.O., and Pascual-Marqui R.D. Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA). Meth. Find. Exp. Clin. Pharmacol. 24 Suppl. C (2002) 97-120
31. Saletu B., Grünberger J., and Linzmayer L. Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry. Int. J. Clin. Pharmacol. Ther. Toxicol. 24 (1986) 362-373
32. Salinsky M.C., Binder L.M., Oken B.S., Storzbach D., Aron C.R., and Dodrill C.B. Effects of gabapentine and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia 43 (2002) 482-490
33. Salinsky M.C., Oken B.S., Storzbach D., and Dodrill C.B. Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures. Epilepsia 44 (2003) 1042-1050
34. Sannita W.G., Gervasio L., and Zagoni P. Quantitative EEG effects and plasma concentration of sodium valproate: acute and long-term administration to epileptic patients. Pharmacoelectroencephalography 22 (1989) 231-235
35. Sommer J.B., Zahner B., Pauli E., and Stefan H. Carbamazepine in patients with epilepsy: subjective complaints but no objective impairment of cognitive function. Epilepsia 40 Suppl. 2 (1999) 96
36. Thatcher R.W., North D., and Biver C. EEG and intelligence: relations between EEG coherence, EEG phase delay and power. Clin. Neurophysiol. 116 (2005) 2129-2141
37. Tuunainen A., Nousiainan U., Pilke A., Mervaala E., Partanen J., and Riekkinen P. Spectral EEG during short-term discontinuation of antiepileptic medication in partial epilepsy. Epilepsia 36 (1995) 817-823